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studyquestion: Can spontaneous premature ovarian failure (POF) patients derived from population-based biobanks reveal the associ-
ation between copy number variations (CNVs) and POF?
summaryanswer: CNVs can hamper the functional capacity of ovaries by disrupting key genes and pathways essential for proper ovarian
function.
what is known already: POF is deﬁned as the cessation of ovarian function before the age of 40 years. POF is a major reason for
female infertility, although its cause remains largely unknown.
studydesign, size, duration: The current retrospectiveCNVstudy included301 spontaneous POFpatients and3188 control indi-
viduals registered between 2003 and 2014 at Estonian Genome Center at the University of Tartu (EGCUT) biobank.
participants/materials, setting, methods: DNA samples from 301 spontaneous POF patients were genotyped by Illu-
mina HumanCoreExome (258 samples) and HumanOmniExpress (43 samples) BeadChip arrays. Genotype and phenotype information was
drawn from the EGCUT for the 3188 control population samples, previously genotyped with HumanCNV370 and HumanOmniExpress Bead-
Chip arrays. All identiﬁed CNVs were subjected to functional enrichment studies for highlighting the POF pathogenesis. Real-time quantitative
PCRwas used to validate a subset of CNVs.Whole-exome sequencingwas performedon six patients carrying hemizygous deletions that encom-
pass genes essential for meiosis or folliculogenesis.
main results and the role of chance: Eleven novel microdeletions and microduplications that encompass genes relevant to
POFwere identiﬁed. Forexample, FMN2 (1q43) and SGOL2 (2q33.1) areessential formeiotic progression,while TBP (6q27), SCARB1 (12q24.31),
BNC1 (15q25) and ARFGAP3 (22q13.2) are involved in follicular growth and oocyte maturation. The importance of recently discovered hemizy-
gous microdeletions of meiotic genes SYCE1 (10q26.3) and CPEB1 (15q25.2) in POF patients was also corroborated.
limitations, reasons for caution: This is a descriptive analysis and no functional studies were performed. Anamnestic data
obtained from population-based biobank lacked clinical, biological (hormone levels) or ultrasonographical data, and spontaneous POF was pre-
dicted retrospectively by excluding known extraovarian causes for premature menopause.
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wider implications of the findings: The present study, with high number of spontaneous POF cases, provides novel data on
associations between the genomic aberrations andprematuremenopauseofovarian cause anddemonstrates thatpopulation-basedbiobanks are
powerful source of biological samples and clinical data to reveal novel genetic lesions associated with human reproductive health and disease,
including POF.
study funding/competing interest: This study was supported by the EstonianMinistry of Education and Research (IUT20-43,
IUT20-60, IUT34-16, SF0180027s10 and 9205), Enterprise Estonia (EU30020 and EU48695), Eureka’s EUROSTARS programme (NOTED,
EU41564), grants from European Union’s FP7 Marie Curie Industry-Academia Partnerships and Pathways (IAPP, SARM, |EU324509) and
Horizon 2020 innovation programme (WIDENLIFE, 692065), Academy of Finland and the Sigrid Juselius Foundation.
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Introduction
Menopause is a normal part of the female aging process. The median
age of natural menopause is approximately 51 years, although variance
in age is strongly determined by genetic (de Bruin et al., 2001) and envir-
onmental factors such as smoking, parity and diet (Lund, 2008).
However, 1% of women experience premature menopause with ces-
sation of ovarian function before the age of 40 (Haller-Kikkatalo et al.,
2015), a condition commonly known as premature ovarian failure
(POF). Owing to estrogen deﬁciency, POF patients suffer from symp-
toms similar to menopause, but also present a higher risk of developing
osteoporosis, cardiovascular diseases and neurodegenerative disorders
(Goswami and Conway, 2005). However, the most widely recognized
effects of POF concern the reproductive system. The ﬁrst symptoms
that usually precedePOFare irregularmenstrual cycles (Haller-Kikkatalo
et al., 2015) and female infertility or pooroutcomeof infertility treatment
(de Boer et al., 2003).
ThedesignationofPOFhasbeenunderdiscussion fora long time,but it is
still preferred amongmany alternatives, including ovarian insufﬁciency, dys-
function or insult (Shelling, 2010). POF is highly heterogeneous and can be
associatedwith iatrogenic factors suchasoophorectomy,ovarian resection
or cystectomy reducing ovarian reserve (Busacca et al., 2006) or chemo-
therapy, and systemic diseases (Group, 2002). Furthermore, to minimize
misinterpretation (Shah and Nagarajan, 2014) we use the term ‘spontan-
eous POF’ to deﬁne retrospectively ovarian quiescence in patients
younger than 40 who do not present with any other known extraovarian
causes for premature menopause. Therefore, spontaneous POF can
arise as a result of noniatrogenic conditions affecting primarily ovaries,
and include autoimmune reactions (Monnier-Barbarino et al., 2005) and
genetic factors (Pouresmaeili and Fazeli, 2014).
Studies of familial spontaneous POF cases showed that genetic back-
ground strongly inﬂuences the onset of POF with familial incidences
ranging from around 4% up to 30% of cases (Cramer et al., 1995;
Conway et al., 1996; Vegetti et al., 1998). Disorders of theX chromosome
are considered to be oneof themain causes of POF, and conventional kar-
yotyping has identiﬁed several X chromosome regions containing genes
required for normal ovarian function (Beke et al., 2013). Mutations in
X-linked genes have been described and include FMR1 (MIM*309550),
BMP15 (MIM*300247)andDACH2 (MIM*300608). Inaddition, someauto-
somal genes are associated with POF, such as GDF9 (MIM*601918), FSHR
(MIM*136435), LHR (MIM*152790) andNR5A1 (MIM*184757) (reviewed
inPersani et al., 2010). Theassociationbetweenmutations inmeiotic genes
and ovarian decline has also been shown in POF patients (Lacombe et al.,
2006; Caburet et al., 2014) and women with 46,XX gonadal dysgenesis
(Zangen et al., 2011), highlighting the importance of meiotic genes in the
regulationofovarian function.Nevertheless, thecauseofprematuremeno-
pause remains unknown in many cases.
AdvancedDNAmicroarray technologies have highlighted the import-
anceof submicroscopic copynumber variations (CNVs) in thepathogen-
esis of rare and complex diseases (Vulto-van Silfhout et al., 2013). CNVs
represent deletions, duplications and insertions that are .1 kb in size
and are present in variable copy number compared with the reference
human genome (Feuk et al., 2006). Associations between CNVs and a
certain disease may reveal novel candidate regions and genes involved
in the pathogenesis of the disease. A limited number of studies have
already demonstrated a possible association between the POF pheno-
type and CNVs. However, most of these studies used low-resolution
array comparative genome hybridization (aCGH) platforms with a
mean spatial resolution of 0.7 Mb or average probe spacing of 21.7 kb
(Aboura et al., 2009; Ledig et al., 2010), or targeted the X chromosome
only (Quilter et al., 2010; Knauff et al., 2011).
Until now, only twoCNV studies in POFpatients used high-resolution
array platforms, either whole-genome SNP array (McGuire et al., 2011)
or a custom-designed aCGH with average probe spacing of 2.2 kb that
targeted genes implicated in gender development (Norling et al.,
2014). Using high-resolution arrays, these studies were able to identify
novel microdeletions and microduplications previously not associated
with POF.However, the cohort sizes of these studies remained relatively
modest, and involved 89 and 26 patients, respectively. Thus, in the
current study we used high-resolution SNP genotyping of 301 spontan-
eous POF patients derived fromEstonianGenomeCenter at theUniver-
sity of Tartu (EGCUT) biobank to reveal novel CNV regions and
candidate genes related to POF phenotype. In addition, whole-exome
sequencing (WES) was performed on genomic DNA of six women
with spontaneous POF carrying hemizygous deletions to determine
whether these deletions can result in unmasking of recessive mutations
in POFcandidategenes in undeleted regionsof thehomologous chromo-
somes, or reveal other POF-associated variants in the exome. The data
reported here reveal new associations between rare CNVs and suscep-
tibility to spontaneous POF. Furthermore, our study indicates that using
samples from population-based biobanks may be a useful and efﬁcient
way to recruit patients for large-scale retrospectiveCNVand disease as-
sociation studies.
Materials andMethods
Ethical approval
The Ethics Review Committee on Human Research of the University of
Tartu and Scientiﬁc Committee of the EGCUT approved this study.
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Population-depictive cohort samples from
EGCUT
EGCUT is the population-based biobank (www.geenivaramu.ee, 6 June
2016, date last accessed) formed according to the Estonian Gene Research
Act and all participants have signed the broad informed consent. The
cohort of EGCUT currently includes .51 000 gene donors over 18 years
of age. EGCUT represents 5% of Estonian population and closely reﬂects
the age, gender and geographical distribution of the Estonian population.
All subjects were recruited randomly and voluntarily by general practitioners
and physicians in hospitals. AComputer Assisted Personal Interview (CAPI)
was completed at a doctor’s ofﬁce and included personal, genealogical, edu-
cational, occupational history and lifestyle data. Anthropometric measure-
ments, blood pressure and resting heart rate were measured, and venous
blood was taken during the visit. Medical history, including parameters of re-
productive health, was collected retrospectively during the recruitment. All
past and current medical conditions were recorded according to the Inter-
national Statistical Classiﬁcation of Diseases (ICD-10) codes.
Women with spontaneous POF
Participants of the study were selected from 34 041 women at the EGCUT
according to phenotype. The ovarian cause for spontaneous premature
menopause was considered if secondary amenorrhea occurred before
the age of 40 years, but no exclusive criteria were reported by participants
or recordedby family physicians. Theexclusive criteriawere: iatrogenicma-
nipulation (surgical hysterectomy, bilateral oophorectomy or unilateral oo-
phorectomy diminishing ovarian reserve, use of oral contraceptives or
other medications causing amenorrhea), comorbidities affecting menstrual
cycle (including obesitywith bodymass index (BMI)≥30 kg/m2, hyperpro-
lactinemia, renal failure and HIV infection), sex chromosome abnormalities
(including Turner syndrome, 46,XY or 47,XXX), developmental disorders
(uterine agenesis), as well as primary amenorrhea. As a result of the selec-
tion, this study included a total of 301 women with spontaneous POF
(Table I). The average age at the time of the study was 57.8+ 12.5 years
(mean+ SD) and on average, 20.7 years had passed since the onset of
menopause, which started at an average age of 37.2 years. The average
BMI value by the time of study was 28.9 kg/m2, indicating overweight
among participants (BMI 25.1–30 kg/m2 indicates overweight and
BMI ≥ 30 kg/m2 stands for obesity). Also, the waist-to-hip ratio of study
participants exceeded 0.8, indicating a moderately increased risk for
being overweight (0.8–0.85 indicatesmoderate risk, while.0.85 indicates
substantial risk).
Since the EGCUT cohort is a volunteer-based longitudinal popula-
tion biobank, additional kinship analysis using the web-based PLINK
v1.07 toolset (http://pngu.mgh.harvard.edu/purcell/plink/, 6 June 2016,
date last accessed) was performed (Purcell et al., 2007) to identify possible fa-
milial cases among the POF patients.
Reference data
TheDatabase of Genomic Variants (DGV; http://dgv.tcag.ca/, 6 June 2016,
date last accessed) was used as a reference dataset to exclude benign poly-
morphisms. DGV holds information on common CNVs found in more
than 20 000 healthy control samples and serves as a catalog of control data
for correlating genomic variation with phenotypic data (MacDonald et al.,
2013). In addition, genotype and phenotype information was drawn for the
Estonian general population samples (n ¼ 3188) from the EGCUT, previous-
ly subjected to SNP genotyping with HumanCNV370 (n ¼ 489) and Huma-
nOmniExpress (n ¼ 2699) BeadChip arrays (Illumina, Inc., San Diego, CA,
USA) to determine and exclude benign population-speciﬁc CNV regions.
The derived EGCUT dataset represented control group of women with
normal age at menopause, as the group included .41 years old pre- and
post-menopausal women, but excluded potential POF cases.
SNP genotyping and CNV calling
The study design is represented schematically in Fig. 1. Inﬁniumw II whole-
genome genotyping assay with HumanOmniExpress (n ¼ 43) or Human-
CoreExome (n ¼ 258) BeadChip arrays (Illumina, Inc.) were used forwhole-
genome SNP genotyping. The HumanOmniExpress BeadChip contains
.715 000 SNP markers with median marker spacing of 2.1 kb, while
HumanCoreExome BeadChip has 547 644 markers, with 265 919 of them
covering exonic regions, and a median marker spacing of 1.9 kb. SNP geno-
typingwet-labexperimentswereperformedaccording to themanufacturer’s
protocols.
Genotypes were called by GenomeStudio software Genotyping Module
v.3.1 (Illumina, Inc.). A call rate of .98% was accepted as the primary
quality control for each sample on both arrays. Log R Ratio and B Allele Fre-
quency values generated by the GenomeStudio software were applied in
further CNV calling using two independent Hidden Markov Model-based
algorithms: QuantiSNP v.2.1 (Colella et al., 2007) and PennCNV (Wang
et al., 2007). Parameters suggested by the authorswere applied to each algo-
rithm. The genomic size threshold for CNVs was set to 50 kb for the Huma-
nOmniExpress array and to 100 kb for the HumanCoreExome array, and
CNV contained at least 10 consecutive SNP markers. To minimize
the number of false-positive ﬁndings, initial CNV calls from the two algo-
rithms were merged and only CNVs called by both algorithms and visually
conﬁrmed in GenomeStudio Genome Viewer were considered for further
data interpretation. All CNVs identiﬁed in this study were submitted
to ClinVar database (http://www.ncbi.nlm.nih.gov/clinvar/, 6 June 2016,
date last accessed; accession numbers SCV000212280 to SCV000212499).
Table I Anamnestic data of 301 women with
spontaneous premature ovarian failure (POF).
Age at study (years) 57.8+12.5
Duration of amenorrhea (years) 20.7+11.6
Smoking status (n)
Never smoked 206 (68.4%, 62.8–73.6)
Former smoker 27 (9.0%, 6.1–12.9)
Current smoker 68 (22.6%, 18.1–27.8)
Height (cm) 163.0+6.5
BMI (kg/m2) 28.9+6.7
Waist-to-hip ratio 0.84+0.08
Age at menarche (years) 13.8+1.7
Length of menstrual cycle at age 25–35
25–29 days 174 (57.8%, 52.0–63.4)
≤20 days 8 (2.7%, 1.2–5.4)
21–24 days 57 (18.9%, 14.8–23.9)
30–35 days 12 (4.0%, 2.2–7.0)
.35 days 1 (0.3%, 0–2.1)
Irregular 25 (8.3%, 5.6–12.2)
Do not know 12 (4.0%, 2.2–7.0)
Duration of fertility (years) 23.6+5.1
Age of 1st pregnancy (years) 22.5+3.6
No. of pregnancies 3.6+2.0
No. of live births 2.0+1.1
Age at menopause (years) 37.2+4.4
Data are means+ SD or count (percentage, 95% CI of percentage).
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For the EGCUT control group, the HumanCNV370 and HumanOmniEx-
pressmicroarray data were processed in the samemanner by performing in-
dependent CNV calling using QuantiSNP and PennCNV and by considering
only CNV regions that were called by both algorithms.
Interpretation of CNV results
The genomic context of aberrant regions was studied using the UCSC
Genome Browser database (http://genome.ucsc.edu/) along with the
OMIM database (www.omim.org, 6 June 2016, date last accessed) to evalu-
ate the potential clinical relevance of a particular CNV. The interpretation of
CNVs was performed according to the ACMG Guidelines (Kearney et al.,
2011). Brieﬂy, chromosomal aberrations were deemed clinically signiﬁcant
if they overlapped with a genomic region associated with a well-established
syndrome or contained a gene or a part of a gene implicated in a known dis-
order. Findings were considered likely benign if they were present in healthy
individuals (e.g..1%ofEstonianpopulationorDGV)and/or theywere gene
deserts or gene-poor regions and/or did not encompass any previously
known disease-associated genes. All remaining ﬁndings were categorized
as variants of unknown clinical signiﬁcance.
Functional analysis of results
Functional annotation and enrichment analysis was carried out using g:
Proﬁler gGOSt web-based software (http://biit.cs.ut.ee/gproﬁler/, 6 June
2016, date last accessed) (Reimand et al., 2007, 2011). The g:Proﬁler public
webserverprovidesacomprehensive setof functionalannotation tools forclus-
tering functionally related genes according to different criteria such as Gene
Ontology terms and biological pathways. Enrichment for functional terms
was considered to be statistically signiﬁcant, if the multiple testing corrected
P-value was ,0.05. A 20 Mb hemizygous deletion on the X chromosome,
found in one of the POF patients, was excluded from the analysis to avoid bias.
CNV validation
Conﬁrmation of a subset of CNVs (n ¼ 14) was done using SYBR-Green
based real-time quantitative PCR (qPCR). CNVs were selected for experi-
mental conﬁrmation if they met the following criteria: (i) there were no
data reported in the DGV and/or CNV was present in ,1% of Estonian
population, and (ii) CNV harbored previously reported POF regions and
genes, or contained genes thatmay potentially impact the age at menopause
based on their biological function. Primers were custom-designed in a web-
based freeware Primer3web (http://primer3.ut.ee/, 6 June 2016, date last
accessed) (Untergasser et al., 2012). A full list of primers used for qPCR ana-
lysis is available upon request. The analysis was performed on a 7900 HT
Real-Time PCR system (Applied Biosystems, Carlsbad, CA, USA). These
data were acquired using SDS 2.2.2 software (Applied Biosystems) and
further processed using qBase+ (Biogazelle, Ghent, Belgium). Analysis was
performed as relative quantiﬁcation using the Pfafﬂ method of calculation
while taking into account the ampliﬁcation efﬁciencies of each primer pair
(Pfafﬂ, 2001). All selected CNVs have been successfully validated.
Figure1 Schematic representationof studydesign.A total of 301 spontaneous prematureovarian failure (POF)patientswere enrolled in the study.After
single nucleotidepolymorphism (SNP) genotyping and copynumber variation (CNV) calling, genome-wideCNV load analysiswasperformedper individual
to estimate the effect of CNV load in the genome on time ofmenopause. Subsequently, all the detectedCNVswere compared against the EGCUT control
population (n ¼ 3188) to identify nonoverlapping CNV regions (CNVRs) (n ¼ 220), for which functional enrichment and association studies were per-
formed. After the following interpretation of each CNVR, six individuals with hemizygous deletions were also selected for whole-exome sequencing
(WES) to determine whether identiﬁed deletions can result in unmasking recessive mutations or other POF-associated variants in the exome.
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Whole-exome sequencing and data analysis
Genomic libraries were prepared according to the Illumina Nextera Rapid
Capture Exome protocol (Illumina, Inc.). The captured libraries were
sequenced on HiSeq2500 platform (Illumina, Inc.) with 2 × 101 bp
paired-end reads, with 92.7% of bases sequenced above the quality of
Q30. Demultiplexing was done with CASAVA 1.8.2. (Illumina, Inc.) allowing
1 mismatch in 8 bp index read. Number of reads varied between samples
from 45 to 56 M.
Sequenced reads were aligned to the human reference genome (hg19,
GRCh37) with the Burrows-Wheeler Aligner (BWA, version 0.6.1). SAM-
tools (version 0.1.18) was used to ﬁlter out reads marked as PCR duplicates
and reads not in a proper read pair. Single-nucleotide substitutions and small
indel variants were then called with GATK, after which variant sites more
than 50 bp away from the nearest exome sequence capture target or with
quality score ,20 were ﬁltered out. Variants were annotated using
in-house developed scripts based on Ensembl API release 75, 1000
Genomes, dbSNP138, ExAC Browser, BIOBASE’s Genome TraxTM data-
base, and in-house whole-exome and whole-genome databases.
Statistical analysis
TheR3.1.0 a Language and Environment (Free Software Foundation, Boston,
MA, USA) was used for statistical analysis. TheWelch two-sample t-test and
the Wilcoxon rank sum test with continuity correction were used to assess
differences in number and size for CNV calling between two SNP-arrays.
Multivariate linear regression models adjusted for confounders were used
to assess the associations between the number and size of CNVs and anam-
nestic data. A P-value of ,0.05 was considered statistically signiﬁcant.
Results
The association between CNV load and
anamnestic data
After applying stringent ﬁltering criteria of initial CNV calls, a total of 346
CNVs were detected on both the X chromosome and autosomal chro-
mosomes in women with spontaneous POF. CNVs identiﬁed by both
algorithms were spread over the entire genome and included 132 copy
number losses (38.2%) and 214 copy number gains (61.8%).
Toestablish theassociationbetween theCNV loadand general repro-
ductive ﬁtness, all identiﬁed CNVs in POF patients and women from the
control groupwhohave reachedmenopause (n ¼ 1735)were subjected
to a global genome-wideCNV load analysis per individual. Linear regres-
sionmodel adjusted by the age ofmenopause and genotyping array attri-
butes did not reveal any difference in the number of CNVs detected
between POF patients and controls (adjusted regression coefﬁcient
(ad r) ¼ 20.012, P ¼ 0.329). Similarly, there were no signiﬁcant differ-
ence in the cumulative size of CNVs detected among POF patients com-
pared with the controls (ad r ¼ 277 658, P ¼ 0.477). Linear regression
model adjusted by genotyping array attributes revealed a negative
association between the number of CNVs in the genome and the age
ofmenopause (ad r ¼ 20.04CNVs per 1 year difference inmenopause,
P ¼ 0.010) in a group of POF patients.When the same model was used
for the control population, no association between the number of CNVs
in the genome and the age of menopausewas observed (ad r ¼ 20.005
CNVs per 1 year difference in menopause, P ¼ 0.709). Also, since
the age at menopause determined the duration of fertility (r ¼ 0.77,
P, 0.00001 for POFpatients and r ¼ 0.84, P, 0.00001 for the control
group), the number of CNVs was also negatively associated with the
duration of fertility in POF patients (ad r ¼ 20.04, P ¼ 0.0008), but
not in the control group (ad r ¼ 20.016, P ¼ 0.216), when the model
was controlled by genotyping array attributes. Linear regression
models were not able to detect any relationships between the number
of CNVs and the length or the regularity of menstrual cycles, the
number of pregnancies or live births, or parameters of body structure.
The cumulative size of CNVs was positively associated with the age at
ﬁrstpregnancy if confounders affecting the ageof pregnancywere consid-
ered in the statistical analysis (linear regression adjusted by age ofmenar-
che, number of live births and age at study, adjusted r ¼ 80.1 kb per one
additional year of the time to ﬁrst pregnancy; P ¼ 0.037). The mean
age+ SD of ﬁrst pregnancy was 22.5+3.6 years and ranged from 15
to 36 years. The associationwas the same if theCNVdetection genotyp-
ing array attributes were also considered (data not shown). This result
suggests that overall CNV load can affect reproductive ﬁtness in terms
of the time of the ﬁrst pregnancy. However, since confounding factors
were not available for the control population, we were not able to
perform similar association study between the cumulative sizes of the
CNVs per genome with the age at ﬁrst pregnancy.
Functional proﬁling of genes within CNV
regions identiﬁes enrichment in pathways
related to the immune system functions
All identiﬁed CNVs were clustered into 95 deleted and 125 duplicated
nonoverlapping copy number variation regions (CNVRs), respectively
(Supplementary data, Table SI). Functional enrichment analysis on
CNVRs was performed using the g:Proﬁler web-based software.
Results of Gene Ontology (GO), KEGG pathway and Reactome
(REAC) datasets with up to third hierarchical level are provided
in Table II. The analysis revealed statistically signiﬁcant networks
related to immunological processes. In particular, a notable number of
genes were involved in chemotaxis of lymphocytes (20.0% of genes,
P ¼ 2.83 × 1022), monocytes (20.4% of genes, P ¼ 8.49 × 1023) and
eosinophils (43.5% of genes, P ¼ 7.68 × 1026). Alterations in KEGG
pathway of ‘chemokine signaling’ (P ¼ 4.11 × 1022), and REAC
pathways of ‘innate immune system’ (P ¼ 2.11 × 1023), ‘adaptive
immune system’ (P ¼ 7.48 × 1025) and ‘scavenging of heme from
plasma’ (P ¼ 2.41 × 10230) were observed in our spontaneous POF
cases.Noneof these functional pathwayswereaffectedby chromosomal
structural rearrangements in women with normal age at menopause,
when a similar analysis was performed for EGCUT control individuals.
These results may underlie the dysregulation of immune system in
patients with spontaneous POF, as numerous interactions between
the immunesystemandovaries are involved in the regulationof thehypo-
thalamic–pituitary–ovarian axis and maintaining growth and regression
of both follicles and corpus luteum (Haller-Kikkatalo et al., 2012).
Detection of potentially relevant regions for
spontaneous POF
Subsequently, clustered CNVRs were screened against the DGV
database to distinguish benign copy number changes from rare POF-
associated CNVs. However, the exclusion of benign polymorphisms
was done with caution, as genetic imbalances affecting gender de-
velopment can depend on the sex of the individual, and this information
is not always available for individuals included in the DGV. In addition,
the Estonian population-based control group was used to exclude
Copy number variation in premature ovarian failure 1917
 at H
elsinki U
niversity Library on N
ovem
ber 18, 2016
http://hum
rep.oxfordjournals.org/
D
ow
nloaded from
 
common variants in the Estonian population. Therefore, in subsequent
case-by-case analyses, 93 out of 125 microduplications and 72 out of
95 microdeletions were classiﬁed as benign polymorphisms, and the
remaining 55 CNVRs were considered to be rare copy number
changes, as they were not reported in DGV nor present in the
EGCUT control group (Supplementary data, Table SII). Emphasis for
selecting CNVs for subsequent validation by qPCR was placed on
unique aberrations that harbored previously reported POF candidate
genes, or contained genes that may potentially impact the age at meno-
pause based on their biological function. Using these criteria, 14 CNVs
were selected as relevant in the susceptibility to POF, andwere success-
fully validated by qPCR. Data from these CNVs, as well as the 20 Mb
hemizygous X chromosome deletion, are summarized in Table III,
while phenotypic data of CNV carriers are given in Table IV.Overlapping
aberrations previously reported in POF patients were identiﬁed in ﬁve
cases: two patients had duplications in the Xp22.31 region (Case14
and Case15) (Quilter et al., 2010), two patients had a 10q26.3 hemizy-
gous deletion (Case7 and Case8) with identical breakpoints (based on
microarray data), and one patient had a 15q25.2 hemizygous deletion
(Case10) (McGuire et al., 2011). All of these women were unrelated
according to kinship analysis. The remaining rare 11 CNVs identiﬁed in
our study were considered to be novel.
Whole-exome sequencing data of six patients
carrying hemizygous deletions
WES was performed on six female carriers of hemizygous deletions
(Tables III and IV) that encompass genes essential for meiosis or follicu-
logenesis. The average read depth for sequenced exomewas 82×.WES
analysis did not reveal any rare POF-associated homozygous variants in
genes within the CNV regions based on ExAC database and in-house
whole-exome and whole-genome reference databases (Supplementary
data, Table SIII). Additionally, WES identiﬁed heterozygous missense
mutation in GDF9 (growth differentiation factor 9 at 5q31.1, rs61754582,
c.1360C . T; p.Arg454Cys) in Case13, when analyzing whole exome
data outside of CNV regions. The prevalence of GDF9 mutations in
POF patients is estimated to be 1–4%, (Dixit et al., 2005; Laissue
et al., 2006;Kovanci et al., 2007;Zhao et al., 2007); however, this particu-
lar variant is present in 0.4% of European population, thus most likely
representing a nonpathogenic variant. In addition, secondary ﬁndings
were identiﬁed by WES that might contribute to comorbid phenotypic
features diagnosed in POF patients (Table V).
Discussion
The current study is the ﬁrst retrospective genetic association study of
spontaneous POF cases using population-based biobank samples. The
main goal of this study was to investigate the role of CNVs in premature
menopausal transition using phenotype and genotype data from the
population-based biobank samples. We found that the overall CNV
load might inﬂuence the age at which an individual transitions to meno-
pause, probably due to an increased chance of disrupting key genes
and pathways that are essential for normal ovarian function. The
number of CNVs was negatively related with the age of menopause in
POF cohort, meaning that in patients with premature menopause the
transition occurred earlier if the genome contained more CNVs. In add-
ition, large structural rearrangements on the X chromosome, and likely
those on autosomes, may disrupt normal chromosomal pairing in
meiosis, leading to germ cell death. Consequently, patients may
develop POF due to the loss of germ cells (Schlessinger et al., 2002).
Still, these associations were observed only in POF patients, but not in
the controls, suggesting the disease-speciﬁc pattern. Therefore, more
studies on healthy populations are warranted to address this question
in greater detail.
In addition, it was observed that larger cumulative size of all CNVs per
individual genome in POF patients was associated with later ﬁrst preg-
nancies. The associationwas quite remarkable as each year of pregnancy
delaywas associatedwith 80 kb bigger size of cumulativeCNV load. This
analysiswas controlledby confounders affecting the timeof theﬁrstpreg-
nancy. Among those, the menarche represented the potential starting
time for pregnancies, the number of live births was considered to unify
the choice for family size, while the age at study was considered to
unify any differences in family planning between generations. As the
result, these data suggest that the overall size of CNVs might be
related to the fecundity of a woman, at least in the POF cohort.
........................................................................................
Table II Signiﬁcant networks identiﬁed by pathway
analysis in spontaneous premature ovarian failure (POF)
patients.
Term ID Term name Level Adjusted
P-valuea
GO:0048247 Lymphocyte chemotaxis 1 2.83 × 1022
GO:0002548 Monocyte chemotaxis 1 8.49 × 1023
GO:0072677 Eosinophil migration 1 4.96 × 1025
GO:0048245 Eosinophil chemotaxis 1.1 7.68 × 1026
KEGG:04062 Chemokine signaling
pathway
1 4.11 × 1022
REAC:168249 Innate immune system 1 2.11 × 1023
REAC:2454202 Fc epsilon receptor
(FCERI) signaling
1.1 5.76 × 1027
REAC:2029480 Fc gamma receptor
(FCGR) dependent
phagocytosis
1.2 2.00 × 10219
REAC:166658 Complement cascade 1.3 2.41 × 10227
REAC:5653656 Vesicle-mediated
transport
1 5.80 × 10210
REAC:2173782 Binding and uptake of
ligands by scavenger
receptors
1.1 3.68 × 10223
REAC:2168880 Scavenging of heme from
plasma
1.1.1 2.41 × 10230
REAC:1280218 Adaptive immune system 1 7.48 × 1025
REAC:198933 Immunoregulatory
interactions between a
lymphoid and a
nonlymphoid cell
1.1 2.05 × 10215
Functional enrichment analysis of genes within rearranged regions was performed
using the web-based g:Proﬁler software. Gene Ontology (GO), KEGG pathway and
Reactome (REAC) datasets with adjusted P-value , 0.05 were considered to be
statistically signiﬁcant.
aMultiple testing corrected enrichment P-value.
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Table III Summary of validated copy number variations (CNVs) in spontaneous premature ovarian failure (POF) cases.
Locus Position (hg19) Length
(kb)
CN Probe
count
Genes within CNV Cases
(n5 301)
Controls
(n5 3188)
CNVcarriers
among cases
(%)
CNV carriers
among controls
(%)
Case ID
1q43 chr1: 240341241–240561727 189.9 1 37 FMN2 1 1 0.33 0.03 Case1
2p13.11 chr2: 73828493–73900329 71.8 1 13 ALMS1, NAT8 1 0 0.33 0 Case2
2q33.1 chr2: 200250898–201845999 1595.1 3 451 SATB2, FTCDNL1, C2orf69, TYW5,
C2orf47, SPATS2L, KCTD18, SGOL2,
AOX1, AOX2P, BZW1, CLK1, PPIL3,
NIF3L1, ORC2, FAM126B
1 1 0.33 0.03 Case3
6q27 chr6: 170713690–170890384 176.7 3 70 FAM120B, PSMB1, TBP, PDCD2 1 1 0.33 0.03 Case4
7p14.3 chr7: 33639870–33730376 90.5 1 30 BBS9 1 10 0.33 0.31 Case5
9q22.31 chr9: 95063947–95179836 115.9 1 70 NOL8, CENPP, OGN, OMD 1 1 0.33 0.03 Case6
10q26.3c chr10: 135256762–135379710 122.9 1 70 CYP2E1, SYCE1 2 3 0.66 0.09 Case7
Case8
12q24.31 chr12: 125260645–125321461 60.8 3 13 SCARB1 1 1 0.33 0.03 Case9
15q25.2c chr15: 83213963–84811815 1597.8 1 325 CPEB1, AP3B2, FSD2,WHAMM,
HOMER2, FAM103A1, C15orf40,
BTBD1, TM6SF1, HDGFRP3, BNC1,
SH3GL3, ADAMTSL3, EFTUD1P1
1 0 0.33 0 Case10
16p13.12 chr16: 13889247–14163635 274.3 3 35 ERCC4 1 0 0.33 0 Case11
17q12 chr17: ×–36220373 1404.8 3 327 ZNHIT3,MYO19, PIGW, GGNBP2,
DHRS11,MRM1, LHX1, AATF, ACACA,
C17orf78, TADA2A, DUSP14, SYNRG,
DDX52, HNF1B
1 8 0.33 0.25 Case12
22q13.2 chr22: 43122720–43500212 377.5 1 54 ARFGAP3, PACSIN2, TTLL1 1 3 0.33 0.09 Case13
Xp22.31d chrX: 6516735–8138080 1618.3 3 111 HDHD1, STS, VCX, PNPLA4 2 21b 0.66 0.66 Case14
Case15
Xq12 chrX: 66905875–67475065 569.2 3 20 AR, OPHN1 1 1 0.33 0.03 Case16
Xq22.1-q24 chrX: 99931059–120328627 20397.6 1 2001 SYTL4. . .GLUD2a 1 0 0.33 0 Case17
All the discrete regions have been validated by qPCR, except for 20 Mb Xq22.1-q24 deletion; del, deletion; dup, duplication; CN, copy number.
a.100 genes in total, ﬁrst and last genes in the region are indicated.
bSTS gene is not covered in any of these 21 control individuals with overlapping Xp22.31 duplications.
cFirst reported by McGuire et al (2010).
dFirst reported by Quilter et al (2010); loci indicated in bold were chosen for subsequent whole-exome sequencing in corresponding CNV carriers.
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Genetic proﬁling and functional enrichment analysis of genes within
identiﬁed CNVRs of POF patients identiﬁed pathways related to
immune system functions. A notable number of genes were associated
with immune cells (e.g. monocytes, lymphocytes) that may inﬂuence
the differentiation andmaturation of germ and granulosa cells (Bukovsky
et al., 1995, 2005; Koks et al., 2010). These ﬁndings are also consistent
...................................................................................................................................................
.............................................................................................................................................................................................
Table IV Phenotype data of premature ovarian failure (POF) patients carrying aberrations with potentially clinical
signiﬁcance.
Case
ID
Locus CN Phenotype
Age at
study
(years)
Age of
menarche
(years)
Age at
menopause
(yr)
No. of
pregnancies
No. of
live
births
Smoking
status
Concomitant diseases
(age of diagnose)
Case1 1q43 1 71 18 40a 4 2 Never
smoked
Hypothyroidism (24 yr);
primary hypertension (67 yr)
Case2 2p13.11 1 53 11 39 3 2 Never
smoked
Adiposity (42 yr);
hypertension with heart
failure (50 yr)
Case3 2q33.1 3 41 11 33 5 2 Never
smoked
Unspeciﬁed arthrosis (35 yr)
Case4 6q27 3 39 12 24 2 1 (IVF) Current
smoker
Arthritis (24 yr); asthma
(29 yr)
Case5 7p14.3 1 58 15 32 4 2 Never
smoked
Allergic contact dermatitis (45
yr); coxarthrosis and
unspeciﬁed rheumatism
(52 yr); post-menopausal
osteoporosis (53 yr); primary
hypertension (55 yr)
Case6 9q22.31 1 68 15 38 2 1 Never
smoked
–
Case7 10q26.3 1 56 13 38 6 3 Never
smoked
Allergic contact dermatitis (45
yr); hypertension with heart
failure (50 yr); unspeciﬁed
polyarthritis (57 yr);
Case8 10q26.3 1 69 18 30 0 0 Never
smoked
Primary bilateral gonarthrosis
(49 yr); hypertension with
heart failure (52 yr); familial
hypercholesterolemia (62 yr);
Type 2 diabetes (67 yr)
Case9 12q24.31 3 51 16 40 1 1 Former
smoker
–
Case10 15q25.2 1 55 13 38 3 2 Never
smoked
–
Case11 16p13.12 3 50 15 39 5 3 Current
smoker
Adiposity (41 yr)
Case12 17q12 3 74 15 39 2 2 Never
smoked
Hypertension with heart
failure (73 yr)
Case13 22q13.2 1 47 13 37 0 0 Current
smoker
–
Case14 Xp22.31 3 52 13 40 1 1 Current
smoker
Spondylosis with
radiculopathy of unspeciﬁed
location (33 yr)
Case15 Xp22.31 3 37 17 37 3 2 Current
smoker
–
Case16 Xq12 3 31 13 25 3 3 Current
smoker
–
Case17 Xq22.1-q24 1 52 12 40 3 2 Never
smoked
–
Subsequent whole-exome sequencing was performed for cases indicated in bold; yr, year.
aAge of 39 years and 6–11 months was rounded to 40 years.
Tsˇuiko et al.1920
 at H
elsinki U
niversity Library on N
ovem
ber 18, 2016
http://hum
rep.oxfordjournals.org/
D
ow
nloaded from
 
..........................................................................................................................................................................................................................................................
Table V Secondary ﬁndings identiﬁed by whole-exome sequencing in six premature ovarian failure (POF) patients.
Case
ID
Gene Transcript Chr Position
(hg19)
rsID Zygosity cDNA Protein ClinVar
accession
Associated phenotype Variant involved in
patient’s
phenotypea
Case1 SCN9A NM_002977.3 2 167136962 rs182650126 Het c.2215A.G p.Ile739Val SCV000191928.1 Small ﬁber neuropathy Not likely
Case1 TMEM43 NM_024334.2 3 14180731 rs113449357 Het c.934C.T p.Arg312Trp SCV000051602.1 Cardiomyopathy Not likely
Case6 SPINK1 NM_003122.4 5 147207583 rs148954387 Het c.194+2T.C p.(-) SCV000253884.1 Hereditary pancreatitis Likely
Case6 NEBL NM_006393.2 10 21157673 rs137973321 Het c.604G.A p.Gly202Arg SCV000062382.3 Cardiomyopathy Uncertain signiﬁcance
Case6 MLH3 NM_001040108.1 14 75514138 rs28756990 Het c.2221G.T p.Val741Phe SCV000026082.1 Endometrial carcinoma Uncertain signiﬁcance
Case6 DSC2 NM_004949.4 18 28672114 rs144799937 Het c.304G.A p.Glu102Lys SCV000063116.3 Cardiomyopathy Uncertain signiﬁcance
Case6 GPR101 NM_054021.1 X 136112910 rs73637412 Het c.924G.C p.Glu308Asp SCV000203835.3 Pituitary adenoma Not likely
Case7 CX3CR1 NM_001171174.1 3 39307162 rs3732378 Het c.839C.T p.Thr280Met SCV000028838.3 Age-related macular
degeneration
Likely
Case7 JAK2 NM_004972.3 9 5073770 rs77375493 Het c.1849G.T p.Val617Phe NA Thrombocythemia Likely
Case7 GPR101 NM_054021.1 X 136112910 rs73637412 Het c.924G.C p.Glu308Asp SCV000203835.3 Pituitary adenoma Not likely
Case8 TNNC1 NM_003280.2 3 52485426 rs267607124 Het c.435C.A p.Asp145Glu SCV000209137.1 Cardiomyopathy Likely
Case8 ANK2 NM_001127493.1 4 114294462 rs121912706 Het c.5434C.T p.Arg1812Trp SCV000223217.2 Arrhythmia Uncertain signiﬁcance
Case10 APOE NM_000041.2 19 45412079 rs7412 Het c.526C.T p.Arg176Cys NA Hyperlipoproteinemia Likely
Case13 BCO1 NM_017429.2 16 81298282 rs119478057 Het c.509C.T p.Thr170Met SCV000025214.2 Hypercarotenemia and
vitamin A deﬁciency
Likely
All data is available upon request. het, heterozygous; NA, not available.
aInvolvement of the variant on comorbid phenotypic features (not in POF syndrome) based on anamnestic data.
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with other studies that implicate humoral and cellular autoimmune
mechanisms in the etiology of POF (Hoek et al., 1997; Chernyshov
et al., 2001). In addition, there was a signiﬁcant alteration in the ‘scaven-
ging of heme fromplasma’ pathway (57.1%of genes, P ¼ 2.41 × 10230).
Free heme has tissue-damaging properties, and it represents a source of
redox-active iron that generates reactive oxygen species (ROS) and oxi-
dative stress (Yamada et al., 2011). The accumulationof damage induced
by ROS is believed to be involved in more rapid ovarian aging due to the
reduced function of oocytes and granulosa cells (Tatone et al., 2008).
In a subsequent case-by-case analysis, we identiﬁed three previously
reported aberrations and 11 novel rare microdeletions and microdupli-
cations that may contribute to spontaneous POF. As a major result, our
data reveal a number of novel candidate genes that are affected by
chromosomal rearrangements and may be potentially involved in the
genetic pathways leading to premature menopause (Supplementary
data, Table SIV). Since spontaneous POF refers to a nonspeciﬁc syn-
drome with many putative risk-genes/regions, the common CNVs are
not expected to be prevalent among POF patients. Indeed; we saw
that detected CNVs are unique to individual POF cases rather than
being common to POF patient population. Therefore, identiﬁed CNVs
are rare and do not succeed in statistical comparisons and P-values (all
being.0.05, data not shown), and thus do not represent any statistically
signiﬁcant differences in the prevalence between the cases and the con-
trols. Still, detectedCNVs can potentially contribute to the onset of pre-
mature menopause based on the biological function of the genes within
CNV regions. In addition; we corroborated the importance of recently
discovered POF genomic regions, including hemizygous microdeletions
of SYCE1 (synaptonemal complex central element protein 1 at 10q26.3,
MIM*611486) and CPEB1 (cytoplasmic polyadenylation element-binding
protein 1 at 15q25.2, MIM*607342) (McGuire et al., 2011). SYCE1 and
CPEB1 have a crucial role in meiosis, maintaining synaptonemal com-
plexes formed between homologous chromosomes (Bolcun-Filas
et al., 2009;Zheng et al., 2010). The involvement of these genes in repro-
ductive failure is supported by knockout mice studies, showing that
knockout female mice are infertile due to meiotic arrest in meiosis I
(Tay and Richter, 2001; Bolcun-Filas et al., 2009). Importantly, the
deleted region on chromosome 15 also encompassed BNC1 (basonuclin
1; MIM*601930) that may also be essential for oogenesis, as oocyte
morphology is affected in knockout mice, which leads to female subfer-
tility (Ma et al., 2006).
Among the genes found within the novel microdeletions, two have a
strong implication in the reproductive biology: FMN2 ( formin 2 at
1q43; MIM*606373) in Case1 and ARFGAP3 (ADP-ribosylation factor
GTPase activating protein 3 at 22q13.2, MIM*612439) in Case13. FMN2
plays a crucial role in cytoskeletal organization and establishment of
cell polarity during oogenesis, which is essential for meiotic maturation
and maintenance of oocyte asymmetry (Montaville et al., 2014). Knock-
out studies in mice revealed that Fmn2-deﬁcient female mice have
decreased fertility due to abnormal metaphase spindle position and ab-
normal ﬁrst polar body formation during meiosis I (Leader et al., 2002).
Notably, FMN2was the only gene disrupted by CNV, and importance of
FMN2 in human reproductionwas also discussed in a case–control study
of women with unexplained infertility (Ryley et al., 2005). The second
gene, ARFGAP3, is an androgen-targeted gene that is thought to be
involved in intracellular trafﬁcking of proteins and in vesicular transport
(Liu et al., 2001). In bovines, ARFGAP3 contributes to follicular growth,
ovulation and/or luteinization (Ndiaye et al., 2005), and it might have a
similar role in human. It is worth noting that whole-exome sequencing
did not reveal any rare homozygous mutations relevant to POF on the
remaining alleles of these deleted regions. This supports the hypothesis
that haploinsufﬁciency of meiotic genes may facilitate germ cell loss,
resulting in premature depletion of the follicular pool. In addition, sec-
ondary ﬁndingswere identiﬁedbyWES, and someof theconditions asso-
ciatedwith the detected variant were also diagnosed in our POF patients
(Table V). POF has an adverse long-term effect on female wellbeing, es-
pecially bone health, cardiovascular health and neurological function
(Shuster et al., 2010); however, it is hard to evaluate retrospectively
whether the identiﬁed variants directly contribute to the disease or the
disease developed as a consequence of premature menopause.
Although the phenotypic consequences of genomic gains are usually
not as straightforward as of deletions, they may impair meiosis or
proper folliculogenesis by altering the gene dosage and expression
level (Newman et al., 2015). Two genomic gains were detected on
X chromosome, and included STS (steroid sulfatase at Xp22.31,
MIM*300747) and androgen receptor (AR at Xq12, MIM*313700)
genes. STS encodes steroid sulfatase that catalysesmetabolic precursors
for estrogens, androgens and cholesterol (Alperin and Shapiro, 1997),
while androgens promote follicular growth at early stages and inhibit at
ﬁnal stages (Sen et al., 2014), similar to polycystic ovary syndrome
(PCOS) (Azziz et al., 2009). Therefore, it is possible that duplications
in these two regions may lead to imbalanced estrogen and/or androgen
levels, subsequently leading to excess of follicular demise. Autosomal
microduplications include meiotic gene SGOL2 (shugoshin-like 2 at
2q33.1, MIM*612425) that protects centromeric cohesion from prema-
ture separase-mediated cleavage in oocytes duringmeiosis I (Llano et al.,
2008).Genomic gain at 6q27 encompassesTBP (TATA box binding protein,
MIM*600075), and mouse studies have revealed that overexpression of
TBP signiﬁcantly lowers the rateofmouseoocyteprogression toMII stage
duringmeiosis, possibly due to a toxic effect on the cell (Sun et al., 2013).
As a result of duplication in Case4, the overexpression of TBP can occur,
causing the failure of oocyte maturation. The 6q27 region also includes
PSMB1 (proteasome subunit, beta-type, 1, MIM*602017), associated with
Sjo¨gren’s syndrome (Martinez-Gamboa et al., 2013), a chronic autoin-
ﬂammatory disease, suggesting autoimmune reactions as the cause of
this patient’s POF at the age of 24 years. SCARB1 (scavenger receptor
class b,member 1 at 12q43; MIM*601040), detected in Case 9, mediates
cholesterol transfer toand fromhigh-density lipoprotein (HDL). It is note-
worthy that this individual has been smoking 10 cigarettes per day for
30 years since the age of 20 years and is overweight (BMI ¼ 30 kg/m2).
SCARB1 knockout mice have abnormal HDLs, ovulation of dysfunctional
oocytes and infertility (Miettinen et al., 2001). SinceHDL is the only lipo-
protein present in follicular ﬂuid (Shalgi et al., 1973; Perret et al., 1985), it
is possible that changes in HDL level due to SCARB1 overproduction,
combined with smoking, may disturb oocyte maturation or function,
and thus contribute to infertility. However, all the gene-dosage hypoth-
eses presented here remain to be tested by future studies.
It is important to note that some CNVs may have gone undetected
due to the set threshold and many high-resolution arrays do not fully
cover the genome (Cooper et al., 2008). In addition to technological
boundaries, our study was limited by the fact that sample selection
from the EGCUTbiobankwas performedonly basedon the available an-
amnestic data, some of which were self-reported as opposed to data
derived directly from medical records. For example, the age at meno-
pause was self-reported on the average 20.7 years later (the duration
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of amenorrhea by the time of study), whichmay lead to reporting errors.
Also, the average age at the time of the study was 57.8+ 12.5 years;
therefore, we lack detailed information on clinical, biological (hormone
levels) or ultrasonographic data, retrospectively from the time of meno-
pause. Moreover, it is not always possible to exclude every disease that
could cause POF secondarily (as opposed to primary ovarian causes).
The shortcomings of this study are diminished by the large cohort size
for such a rare disease and the close examination of a wide range of
phenotypic data in every patient.
In summary, our data provide novel insight into the association
between chromosomal aberrations and premature menopause of
ovarian cause. Our results highlighted the possible role of CNVs in the
pathogenesis of POF. Both duplications and deletions detected in our
study were associated with the POF phenotype and contained genes
that are essential for reproductive function. Although functional
studies are required to further delineate the contribution of identiﬁed
CNVs in the genetic etiology of POF, our study conﬁrms that DNA
microarrays are a useful tool for evaluating genomic imbalances in POF
patients as it offers amuch higher resolution and therefore, a higher diag-
nostic yield compared with conventional cytogenetic methods. Finally,
we conclude that using samples from population-based biobanks may
be a useful and efﬁcient way to recruit patients for large-scale CNV
studies, and data collected from such studies represent a starting
point for both characterization of the disease and guidance for further
research.
Supplementary data
Supplementarydata areavailable athttp://humrep.oxfordjournals.org/.
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